Skip to content
Open access

Polyherbal Formulation Development and Therapeutic Assessment for the Management of Type 2 Diabetes Mellitus

Oct 2026 · Oriental Journal of Chemistry · 0 citations · 10 references

Abstract

Background: Type 2 diabetes mellitus (T2DM) is a worldwide epidemic that affects more than 530 million people, where traditional single-target based therapy can often have side effects, affordability issues, and fail to consider the multifactorial nature of the disease. Phytochemical synergism in polyherbal formulations is a promising option, as it allows them to address multiple pathogenic pathways. The present study was undertaken to formulate and test a polyherbal tablet of Syzygium cumini, Allium sativum, Moringa oleifera and Camellia sinensis for T2DM. For the method, the extracts were prepared by using hydroalcoholic extract procedure, concentrated and lyophilized for four plant materials. The tablets were optimized by using 3² full factorial design technique followed by direct compression method for the formulation of the polyherbal tablets.The polyherbal tablets were formulated by direct compression method and optimized by 3² full factorial design technique. Qualitative phytochemical screening and quantitative estimation of bioactive markers (quercetin, ellagic acid, alliin, EGCG and chlorogenic acid) using HPTLC and HPLC and physicochemical characterization of the extracts and formulation were carried out. Antidiabetic activity was determined by the ability of the extract to inhibit α-amylase and α-glucosidase, and antioxidant activity was determined by using DPPH and FRAP methods. The combination index (CI) method was used to determine synergistic interactions. Results: The polyherbal formulation had a wide phytochemical spectrum, with significant levels of quercetin (1.52 ± 0.05 mg/tablet), EGCG (1.41 ± 0.04 mg/tablet), chlorogenic acid (0.97 ± 0.03 mg/tablet), ellagic acid (0.75 ± 0.03 mg/tablet), and alliin (0.58 ± 0.02 mg/tablet). The optimized tablets had excellent physicochemical properties, with hardness 6.4 ± 0.5kg/cm² and friability 0.68 ± 0.12% and the disintegration time was 6.2 ± 0.8min. It exhibited strong α-amylase inhibitory activity (IC₅₀: 28.6 ± 1.3 µg/mL) and α-glucosidase inhibitory activity (IC₅₀: 18.2 ± 0.9 µg/mL) compared to the standard drug acarbose. It also exhibited superior antioxidant activity (DPPH IC₅₀: 18.4 ± 0.9 µg/mL; FRAP: 456.2 ± 19.3 µmol Fe²⁺/g). Combination index analysis showed that all activities tested exhibited synergistic interactions (CI: 0.58–0.72). Conclusion: The polyherbal formulation exhibited considerable in vitro antidiabetic and antioxidant potential via synergistic multi-target mechanism, establishing its therapeutic potential as a safe, effective and economical strategy for diabetic management of T2DM. These results indicate that they need further in vivo and clinical testing.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.